New treatments in type 2 diabetes: a focus on the incretin-based therapies.

Abstract:

:The demonstration that the incretin hormone glucagon-like peptide 1 can improve glycaemic control in patients with type 2 diabetes has led to the rapid development during the last decade of promising new classes of agent for the management of type 2 diabetes. These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of glucose-dependent insulin secretion, suppression of glucagon secretion, slowing of gastric emptying, and reduction of food intake. In addition, preclinical studies suggest that incretin-based therapies may improve beta-cell function via enhancement of beta-cell mass and induction of genes important for differentiated beta-cell function. Exenatide, and the dipeptidyl peptidase-4 inhibitors, sitagliptin and vildagliptin are already approved, and liraglutide is currently completing Phase 3 trials. As these agents and standard oral therapies for type 2 diabetes lower glucose levels through different, but potentially complementary mechanisms, their use in combination should provide effective, potentially additive, glycaemic control. The incretin-based therapies also offer other advantages such as weight loss with exenatide and liraglutide, a reduced risk of hypoglycaemia, and as suggested by preclinical studies, a potential beta-cell preserving effect. Long-term outcome and safety data are not available for these agents, but they appear generally well-tolerated in comparison with existing therapies for type 2 diabetes. The multiple underlying glucose-lowering actions of the incretin-based therapies, as well as a lack of weight gain or even weight loss, make these important new additions to available antidiabetic agents expanding the treatment options available for patients.

journal_name

Clin Endocrinol (Oxf)

journal_title

Clinical endocrinology

authors

Barnett AH

doi

10.1111/j.1365-2265.2008.03396.x

subject

Has Abstract

pub_date

2009-03-01 00:00:00

pages

343-53

issue

3

eissn

0300-0664

issn

1365-2265

pii

CEN3396

journal_volume

70

pub_type

杂志文章,评审
  • The secretion of thyrotrophin with impaired biological activity in patients with hypothalamic-pituitary disease.

    abstract::We describe here two patients with hypothyroidism due to pituitary-hypothalamic disease in whom basal thyrotrophin (TSH) levels measured by radioimmunoassay (RIA) were elevated yet when measured by a cytochemical bioassay (CBA) were found to be normal. This finding and the absence of the normal rise of thyroid hormone...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1978.tb02174.x

    authors: Petersen VB,McGregor AM,Belchetz PE,Elkeles RS,Hall R

    更新日期:1978-05-01 00:00:00

  • Hyperthyroidism associated with metastatic thyroid carcinoma.

    abstract::We report a patient with unilateral thyroid carcinoma, who developed hyperfunction of the thyroid gland during the metastatic progression of the thyroid carcinoma. Concurrently with this event, TSI increased and it is suggested that the differentiated aggressive metastatic thyroid neoplasm had initiated the autoimmune...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1994.tb01837.x

    authors: Steffensen FH,Aunsholt NA

    更新日期:1994-11-01 00:00:00

  • Structure activity studies on somatostatin.

    abstract::Seven synthetic analogues of somatostatin helped clarify structural requirements for suppression of growth hormone secretion in rats. Size of the ring is not critical; deletions of serine-13, lysine-4 or asparagine-5 result in peptides which retain an appreciable fraction of the activity. The analogue des-Ala1, Gly2, ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1976.tb03835.x

    authors: Sarantakis D,McKinley WA,Jaunakais I,Clark D,Grant NH

    更新日期:1976-01-01 00:00:00

  • Calcium and parathyroid hormone behaviour after exogenous secretin infusion in man.

    abstract::The response of serum calcium, PTH, CT and gastrin to an infusion of secretin (3 CU/kg/h) over a period of 90 min was studied in ten healthy males and two female patients with hypoparathyroidism. In the healthy males serum calcium, after a transient fall, significantly increased at 45 min after the onset of the infusi...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1982.tb00724.x

    authors: Lo Cascio V,Piubello W,Cominacini L,Vantini I,Galvanini G,Ederle A,Cavallini G,Scuro LA

    更新日期:1982-04-01 00:00:00

  • Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy.

    abstract:OBJECTIVE:We aimed to evaluate and contrast the hypothalamo-pituitary-adrenal (HPA) response to direct current (DC) cardioversion and electroconvulsive therapy (ECT). SUBJECTS:Six male subjects (mean age 61.2 years, range 46-74) with chronic atrial fibrillation were selected for cardioversion. Six subjects with depres...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1996.642464.x

    authors: Florkowski CM,Crozier IG,Nightingale S,Evans MJ,Ellis MJ,Joyce P,Donald RA

    更新日期:1996-02-01 00:00:00

  • Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations.

    abstract:BACKGROUND:Hydrocortisone therapy should be individualized in congenital adrenal hyperplasia (CAH) patients to avoid over and under replacement. We have assessed how differences in absorption and half-life of cortisol influence glucocorticoid exposure. PATIENTS AND METHODS:Forty-eight patients (21 M) aged between 6·1 ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12653

    authors: Hindmarsh PC,Charmandari E

    更新日期:2015-04-01 00:00:00

  • End-organ responses to thyroxine therapy in subclinical hypothyroidism.

    abstract::We studied variables known to change with thyroid hormone status in 18 patients with subclinical hypothyroidism before and during treatment with thyroxine in a dose sufficient to restore the plasma TSH response to TRH to normal. There was an associated increase in both plasma total T4 and free T4 within the normal ran...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1985.tb01068.x

    authors: Bell GM,Todd WT,Forfar JC,Martyn C,Wathen CG,Gow S,Riemersma R,Toft AD

    更新日期:1985-01-01 00:00:00

  • Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast.

    abstract:OBJECTIVE:PTH(1-84) secretion in normal male subjects follows a circadian rhythm. The control of this rhythm is multifactorial with both neuroendocrine and chemical influences. The aim of this study was to assess the effect of a 96-hour fast on the circadian rhythm of PTH(1-84), serum calcium, phosphate and nephrogenou...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2265.1994.tb02493.x

    authors: Fraser WD,Logue FC,Christie JP,Cameron DA,O'Reilly DS,Beastall GH

    更新日期:1994-04-01 00:00:00

  • Lack of correlation between phenotype and genotype in untreated 21-hydroxylase-deficient Indonesian patients.

    abstract:BACKGROUND:Mutations in CYP21A2 lead to deficiency of 21-hydroxylase and can have either severe or moderate effects on phenotype, which can be prevented by early treatment. We studied long-term effects of this deficiency on phenotype in patients who had not been treated for prolonged periods and correlated these phenot...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2009.03550.x

    authors: Goossens K,Juniarto AZ,Timmerman MA,Faradz SM,Wolffenbuttel KP,Drop SL,de Jong FH

    更新日期:2009-11-01 00:00:00

  • The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome.

    abstract:BACKGROUND:Peroxisomal proliferator-activated receptors (PPAR)- gamma are expressed abundantly in ACTH-secreting pituitary tumours. The PPAR-gamma activator rosiglitazone has been shown to suppress ACTH secretion in human adrenocorticotroph tumour cells in vitro, and prevent and reduce adrenocorticotroph tumour develop...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2006.02501.x

    authors: Mullan KR,Leslie H,McCance DR,Sheridan B,Atkinson AB

    更新日期:2006-05-01 00:00:00

  • Responses to the 35% CO challenge in postpartum women.

    abstract::Lactation has been associated with suppression of some components of the neuroendocrine stress response. In humans, suppression of the hypothalamo-pituitary-adrenal (HPA) axis has been demonstrated in response to both a psychological and an exercise challenge, but appears to be limited to a short period of time follow...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2004.02133.x

    authors: Kaye J,Soothill P,Hunt M,Lightman S

    更新日期:2004-11-01 00:00:00

  • A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.

    abstract:OBJECTIVE:The autoimmune thyroid diseases, Graves disease and autoimmune hypothyroidism, result from a complex interaction between genetic, environmental and endogenous factors. The genetic loci conferring susceptibility remain unclear. A recent report has demonstrated an association between a microsatellite polymorphi...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1997.1710996.x

    authors: Kotsa K,Watson PF,Weetman AP

    更新日期:1997-05-01 00:00:00

  • Milk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients.

    abstract:OBJECTIVE:Milk-alkali syndrome, once a common cause of hypercalcaemia, is now considered rare. Our aim was to estimate the prevalence of milk-alkali syndrome among hypercalcaemic, non-end-stage renal disease (non-ESRD) inpatients of a University Hospital and identify patients' and syndrome characteristics. DESIGN AND ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2005.02383.x

    authors: Picolos MK,Lavis VR,Orlander PR

    更新日期:2005-11-01 00:00:00

  • Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.

    abstract:OBJECTIVE:We examined the obesity phenotype most strongly associated with increased plasma concentrations of sTNFR2, and compared which of the two markers, TNF-alpha or sTNFR2, better predicts indices of plasma glucose-insulin homeostasis. DESIGN, PATIENTS AND MEASUREMENTS:Plasma sTNFR2 levels were measured in a sampl...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2009.03671.x

    authors: Cartier A,Côté M,Bergeron J,Alméras N,Tremblay A,Lemieux I,Després JP

    更新日期:2010-03-01 00:00:00

  • Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood.

    abstract:OBJECTIVE:In January 1997 we introduced a protocol for the treatment with GH of children with impaired growth after unfractionated total body irradiation (TBI). This study is an evaluation of that protocol. PATIENTS AND METHODS:Between January 1997 and July 2005, 66 patients (48 male) treated for haematological malign...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2265.2007.02930.x

    authors: Bakker B,Oostdijk W,Geskus RB,Stokvis-Brantsma WH,Vossen JM,Wit JM

    更新日期:2007-10-01 00:00:00

  • Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy.

    abstract:BACKGROUND:Recent evidence has shown that oxidative stress may play a role in the pathogenesis of autoimmune diseases, and this is an issue of considerable research interest in the field of infiltrative ophthalmopathy. Therefore, we evaluated both the relationship between Graves' ophthalmopathy (GO) and serum levels of...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2010.03904.x

    authors: Akarsu E,Buyukhatipoglu H,Aktaran S,Kurtul N

    更新日期:2011-01-01 00:00:00

  • Radioiodine treatment for benign thyroid diseases.

    abstract::Radioiodine has been in use for over 60 years as a treatment for hyperthyroidism. Major changes in clinical practice have occurred with the realization that accurate dosimetry is incapable of avoiding the risks of hypothyroidism, while more accurate assessment of the risks of other adverse effects of radioiodine such ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,实务指引

    doi:10.1111/j.1365-2265.2007.02841.x

    authors: Weetman AP

    更新日期:2007-06-01 00:00:00

  • Diagnostic performance of HMGA2 gene expression for differentiation of malignant thyroid nodules: A systematic review and meta-analysis.

    abstract:OBJECTIVE:The purpose of the current study was to investigate the diagnostic performance of high mobility group A2 (HMGA2) gene expression for differentiation of malignant thyroid nodules through a systematic review and meta-analysis. DESIGN:The MEDLINE/PubMed and EMBASE database, from the earliest available date of i...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,meta分析

    doi:10.1111/cen.13853

    authors: Kim BH,Kim SJ,Kim M,Lee SW,Jeong SY,Pak K,Kim K,Kim IJ

    更新日期:2018-12-01 00:00:00

  • Effects of exercise training on maternal hormonal changes in pregnancy.

    abstract:CONTEXT & OBJECTIVE:A recent paper by our group reported that regular aerobic exercise during pregnancy led to lower foetal IGF-I and IGF-II concentrations and a modest reduction in offspring birth weight when compared with the offspring of nontraining control participants. Maternal hormonal alterations in response to ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1365-2265.2010.03964.x

    authors: Hopkins SA,Baldi JC,Cutfield WS,McCowan L,Hofman PL

    更新日期:2011-04-01 00:00:00

  • Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination.

    abstract::3-M syndrome is an autosomal recessive primordial growth disorder characterized by small birth size and post-natal growth restriction associated with a spectrum of minor anomalies (including a triangular-shaped face, flat cheeks, full lips, short chest and prominent fleshy heels). Unlike many other primordial short st...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1365-2265.2012.04428.x

    authors: Clayton PE,Hanson D,Magee L,Murray PG,Saunders E,Abu-Amero SN,Moore GE,Black GC

    更新日期:2012-09-01 00:00:00

  • The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.

    abstract::In order to investigate the mechanism of GIP secretion and the role of endogenous GIP in the enteroinsular axis in duodenal ulcer patients, we have compared plasma GIP, insulin, and blood glucose responses to oral glucose ingestion in 10 duodenal ulcer patients, 5 patients with total gastrectomy, and 20 normal subject...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1983.tb00008.x

    authors: Takemura J,Seino Y,Yamamura T,Yoshiya K,Ishikawa Y,Itoh N,Imura H

    更新日期:1983-09-01 00:00:00

  • Prolactin pulsatility in patients with gonadal dysfunction.

    abstract::Serum prolactin concentrations have been measured at 15 min intervals for 2 h on 240 occasions in 227 patients with symptoms which could have been due to hyperprolactinaemic gonadal dysfunction. Of the 227, 138 had at least one elevated random prolactin level. Overall, 22% showed no significant fluctuation in prolacti...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1981.tb00625.x

    authors: Moult PJ,Dacie JE,Rees LH,Besser GM

    更新日期:1981-04-01 00:00:00

  • Phenotypic and molecular characteristics in eleven Chinese patients with 5α-reductase Type 2 deficiency.

    abstract:CONTEXT:Steroid 5α-reductase type 2 deficiency (5α-RD2) is a male-limited, autosomal recessive inherited disease. Affected 46, XY individuals usually present with ambiguous genitalia at birth. An early and precise diagnosis is of great value to the long-term prognosis of the disease. OBJECTIVE:To describe the clinical...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12456

    authors: Zhu H,Liu W,Han B,Fan M,Zhao S,Wang H,Lu Y,Pan C,Chen F,Chen M,Song H,Cheng K,Qiao J

    更新日期:2014-11-01 00:00:00

  • Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group.

    abstract:OBJECTIVE:The goal of our study was to determine the rate of neoplasms in patients with other pituitary adenomas (non-functioning and prolactinomas) in comparison with acromegaly which is known to favour the development of neoplasia. DESIGN AND PATIENTS:We reviewed clinical records for 220 patients with acromegaly, 15...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1998.00536.x

    authors: Popovic V,Damjanovic S,Micic D,Nesovic M,Djurovic M,Petakov M,Obradovic S,Zoric S,Simic M,Penezic Z,Marinkovic J

    更新日期:1998-10-01 00:00:00

  • Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.

    abstract::It has been reported that administration of nomifensine (Nom) or of L-dopa + carbidopa (L-dopa + Carb) potentiates central dopaminergic tonus, resulting in decreased prolactin (PRL) secretion. It has been proposed that these drugs would help to discriminate patients with PRL-secreting pituitary tumours from those with...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1980.tb03420.x

    authors: Moriondo P,Travaglini P,Nissim M,Faglia G

    更新日期:1980-12-01 00:00:00

  • Acid glycosaminoglycans in myxoedema.

    abstract::Acid glycosaminoglycans were measured in the tissues of a virtually untreated 83-year-old woman with myxoedema. Intercellular oedema was demonstrated histologically in the tongue, myocardium, striated muscles, and in the skin. Tissue oedema was absent in two female control patients. All tissues from the patient with m...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1982.tb03166.x

    authors: Parving HH,Helin G,Garbarsch C,Johansen AA,Jensen BA,Helin P,Lund P,Lyngsøe J

    更新日期:1982-02-01 00:00:00

  • Changing trends in incidence and mortality of thyroid cancer in Scotland.

    abstract:OBJECTIVE:The incidence of thyroid cancer is increasing in several countries. The aim was to investigate trends in the incidence and mortality of thyroid cancer in Scotland, where thyroid cancer is relatively uncommon, between 1960 and 2002. DESIGN:Descriptive epidemiological study. METHODS:Thyroid cancer registratio...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2004.02187.x

    authors: Reynolds RM,Weir J,Stockton DL,Brewster DH,Sandeep TC,Strachan MW

    更新日期:2005-02-01 00:00:00

  • Social, educational and vocational outcomes in patients with childhood-onset and young-adult-onset growth hormone deficiency.

    abstract:OBJECTIVE:Hypopituitarism diagnosed in childhood, adolescence and young adulthood has the potential to affect growth and somatic development. Less is known about the impact of such a diagnosis on other aspects of development. DESIGN:An analysis of the KIMS database (Pfizer International Metabolic Database) was perform...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.13291

    authors: Mitra MT,Jönsson P,Åkerblad AC,Clayton P,Kołtowska-Häggström M,Korbonits M,Toogood A,Gleeson H

    更新日期:2017-04-01 00:00:00

  • Normocalcaemic primary hyperparathyroidism: An update on diagnostic and management challenges.

    abstract::Normocalcaemic primary hyperparathyroidism is a condition that can present with intermittent hypercalcemia or may evolve into hypercalcemic primary hyperparathyroidism. This milder biochemical entity remains incompletely understood because of a lack of long-term health outcomes regarding both medical and surgical appr...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,评审

    doi:10.1111/cen.14315

    authors: Dawood NB,Yan KL,Shieh A,Livhits MJ,Yeh MW,Leung AM

    更新日期:2020-11-01 00:00:00

  • Normal final height and apparent cure after pituitary irradiation for Cushing's disease in childhood: long-term follow-up of anterior pituitary function.

    abstract::Pituitary-dependent Cushing's syndrome is rare in childhood. Two patients are reported who had unsuccessful transsphenoidal microadenomectomy and therefore underwent pituitary radiotherapy. In both patients there was progressive normalization of hypothalamo-pituitary-adrenal function and at 8 and 10 years after radiot...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1998.00385.x

    authors: Johnston LB,Grossmann AB,Plowman PN,Besser GM,Savage MO

    更新日期:1998-05-01 00:00:00